Praxis Medicines (PRAX) - Market Capitalization
The price trend visualization for Praxis Precision Medicines (PRAX) demonstrates the dynamics of an asset with a market capitalization of 9.16. Praxis Precision Medicines (PRAX) relies on US laboratories that develop high-precision brain medications using advanced genetic systems. However, the business faces volatile trial data swings and an intensive cash burn. Its narrow CNS profile is offset by a priority on rare forms of epilepsy with a streamlined registration process.
PRAX (Praxis Corp): analytical breakdowns and indicator data
- market price and analyst price targets:
- market capitalization indicators:
- issuer book value statistics:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Praxis Precision Medicines|PRAX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Praxis Precision Medicines|PRAX - Company Aggregate Debts|Debt to Book Capitalization Ratio Praxis Corp|PRAX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Praxis Precision Medicines|Quick Liquidity praxismedicines.com
- net income and valuation multiples indicators:
PRAX - Profit After Tax|Expected Profit Praxis Precision Medicines|PRAX - Company Value to Net Income|Forward P/E Multiple Praxis Medicines|PRAX - PEG Multiple|Enterprise Value to EBITDA Ratio Praxis Corp|PRAX - Operating profit before amortization|Net earnings per share (EPS TTM) Praxis Precision Medicines|PRAX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months praxismedicines.com|PRAX - Expected net earnings per share growth this year|Expected earnings per share growth for next year Praxis Precision Medicines
- sales and revenue indicators:
Fundamental company analysis:PRAX (Praxis Precision Medicines, Inc.)
Market value dynamics reflect the market valuation of total assets and operational efficiency, where high capitalization provides resilience against volatility but may constrain profit growth rates. For a CNS therapy biotech visionary with strong scientific authority, this indicator confirms the medical community's confidence in the developments of Praxis Precision Medicines (PRAX), as clearly illustrated by the company's capitalization trends.
Key competitors
Market Value Biogen BIIB|Market Value NBIX|Regencell - Market Capitalization|AXSM - Market Capitalization|ACAD (ACADIA Pharmaceuticals) - Market Valuation|Market Capitalization XENE|Market Value Viking Therapeutics, Inc.|Market Capitalization SUPN (Supernus Pharmaceuticals, Inc.)|Market Capitalization CPRX|DNLI - Market Value|Harmony Biosciences - Market Valuation|Market Capitalization biohavenpharma.com BHVN|AMLX - Market Value|Market Value TRVI (Trevi Therapeutics Inc)|Anavex Corp (AVXL) - Market Value|Market Value CeriBell EEG (CBLL)|Market Value Prothena Corporation PLC|Alector Therapeutics - Market Valuation|Market Value Annexon (ANNX)|OMER (omeros.com) - Market Value|Market Capitalization NGNE (Neurogene Corp)|Market Capitalization AC Immune Inc ACIU|VYGR: Market Valuation|NMRA (neumoratx.com) - Market Capitalization|SCLX: Market Capitalization|TVGN - Market Capitalization|Market Value Alpha Cognition Inc|cogrx.com (CGTX) - Market Capitalization|Market Valuation IKT (Inhibikase Therapeutics)|SAVA (cassavasciences.com) - Market Value|Market Value Assertio ASRT|COYA (Coya Therapeutics Inc) - Market Valuation|VTGN - Market Value|Market Value OVID (Ovid Therapeutics Inc.)|ABOS: Market Capitalization|Market Value cervomed.com (CRVO)|ATHE (Alterity Therapeutics Ltd.) - Market Capitalization|Market Valuation Clene Nanomedicine (CLNN)|Market Capitalization PEPG|Market Capitalization jupiterneurosciences.com|Market Value Relmada Therapeutics RLMD|Market Capitalization annovisbio.com (ANVS)|Grace Tx - Market Capitalization|Market Capitalization Firefly Neuroscience, Inc. AIFF|anewmeds.com (KLTO) - Market Value|Market Value NeuroSense Therapeutics Ltd. (NRSN)|Market Value Reviva Pharmaceuticals|Market Capitalization MTVA (MetaVia, Inc.)|Market Valuation NRXS (NeurAxis)|HSDT (heliusmedical.com) - Market Value|Market Value Passage Bio PASG|NEUP - Market Valuation|Minerva Neurosciences - Market Capitalization|Market Value athira.com|ADXN: Market Capitalization|Market Capitalization ALZN|CYCN (Cyclerion Therapeutics Inc.) - Market Capitalization|Protagenic (PTIX) - Market Capitalization|Market Capitalization KTTA|Market Valuation cortigent.com CRGT|Market Capitalization ATXI (Avenue Therapeutics, Inc.)|Market Capitalization Brainstorm Cell Therapeutics Inc. (BCLI)|CARA - Market Value|CHRO (Chromocell) - Market Capitalization|ELYM: Market Capitalization|Market Value Intra-Cellular Therapies, Inc. (ITCI)|Market Value Longboard Pharmaceuticals, Inc.|Marinus Pharmaceuticals Inc (MRNS) - Market Capitalization|Market Value NKGen (NKGN)|NRBO: Market Valuation|Market Value Sage Therapeutics, Inc. SAGE|Market Value SNPX|Trevena - Market Capitalization|VIGL - Market Capitalization|WENA (Anew Medical, Inc.) - Market Valuation|Market Capitalization CERE
